Showing results (1-10 of 169) with videos related to
Sort By:
Pageof 17
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 1, 2006
Mechanistic rationale and clinical evidence for the efficacy of proteasome inhibitors against indolent and mantle cell lymphomasLuca Paoluzzi, Owen A O'ConnorAdvances in Experimental Medicine and Biology|October 6, 2010
Targeting survival pathways in lymphomaLuca Paoluzzi, Owen A O'ConnorHematology/Oncology Clinics of North America|October 29, 2008
New drugs for the treatment of lymphomaLuca Paoluzzi, Yukiko Kitagawa, Matko Kalac, et al.British Journal of Haematology|July 17, 2009
The anti-histaminic cyproheptadine synergizes the antineoplastic activity of bortezomib in mantle cell lymphoma through its effects as a histone deacetylase inhibitorLuca Paoluzzi, Luigi Scotto, Enrica Marchi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphomaLuca Paoluzzi, Luigi Scotto, Enrica Marchi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2010
Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignanciesEnrica Marchi, Luca Paoluzzi, Luigi Scotto, et al.Leukemia & Lymphoma|April 11, 2015
The novel kinesin spindle protein (KSP) inhibitor SB-743921 exhibits marked activity in in vivo and in vitro models of aggressive large B-cell lymphomaDanielle Bongero, Luca Paoluzzi, Enrica Marchi, et al.Clinical Sarcoma Research|December 12, 2018
Extraskeletal myxoid chondrosarcoma with massive pulmonary metastasesLuca Paoluzzi, Munir GhesaniClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Development and characterization of a novel CD19CherryLuciferase (CD19CL) transgenic mouse for the preclinical study of B-cell lymphomasLuigi Scotto, Marianna Kruithof-de Julio, Luca Paoluzzi, et al.Cancer Biology & Therapy|May 12, 2004
Histone deacetylase inhibitors are potent radiation protectantsLuca Paoluzzi, William D FiggPageof 17